Eli Lilly & Co. (LLY)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
11-Jun-21 10:35 AM
View: 
Lilly Endowment Inc
10% Owner
Eli Lilly & Co. (LLY) 10-Jun-21Market Sale 240,000$233.63$56,072,400.00(< 1%)
109.65M to 109.41M
< 1%
10-Jun-21 3:35 PM
View: 
Lilly Endowment Inc
10% Owner
Eli Lilly & Co. (LLY) 09-Jun-21Market Sale 220,000$224.93$49,484,300.00(< 1%)
109.87M to 109.65M
(< 1%)
08-Jun-21 3:16 PM
View: 
Lilly Endowment Inc
10% Owner
Eli Lilly & Co. (LLY) 07-Jun-21Market Sale 230,000$224.72$51,685,000.00(< 1%)
110.1M to 109.87M
< 1%
25-May-21 10:39 AM
View: 
Lilly Endowment Inc
10% Owner
Eli Lilly & Co. (LLY) 24-May-21Market Sale 7,329$202.27$1,482,410.00(< 1%)
110.11M to 110.1M
< 1%
24-May-21 11:15 AM
View: 
Lilly Endowment Inc
10% Owner
Eli Lilly & Co. (LLY) 21-May-21Market Sale 92,740$200.58$18,602,000.00(< 1%)
110.2M to 110.11M
< 1%
21-May-21 12:57 PM
View: 
Lilly Endowment Inc
10% Owner
Eli Lilly & Co. (LLY) 20-May-21Market Sale 99,931$200.48$20,033,800.00(< 1%)
110.3M to 110.2M
< 1%
19-May-21 4:35 PM
View: 
Tai Jackson P
Director
Eli Lilly & Co. (LLY) 17-May-21Grant 10$195.53$1,955.30< 1%
61.2K to 61.2K
(< 1%)
19-May-21 4:30 PM
View: 
Johnson Kimberly H
Director
Eli Lilly & Co. (LLY) 17-May-21Grant 49$195.53$9,580.9748%
0.1K to 0.15K
(< 1%)
19-May-21 4:27 PM
View: 
Alvarez Ralph
Director
Eli Lilly & Co. (LLY) 17-May-21Grant 56$195.53$10,949.70< 1%
49.52K to 49.57K
(< 1%)
03-May-21 7:01 PM
View: 
Tai Jackson P
Director
Eli Lilly & Co. (LLY) 30-Apr-21Market Purchase 1,366$182.84$249,759.002%
59.83K to 61.2K
(< 1%)
29-Apr-21 8:31 PM
View: 
Zakrowski Donald A
Chief Accounting Officer
Eli Lilly & Co. (LLY) 28-Apr-21Market Sale 3,000$181.38$544,140.00(28%)
10.65K to 7.65K
< 1%
21-Apr-21 4:23 PM
View: 
Alvarez Ralph
Director
Eli Lilly & Co. (LLY) 19-Apr-21Grant 58$189.64$10,999.10< 1%
49.46K to 49.52K
< 1%
21-Apr-21 4:32 PM
View: 
Tai Jackson P
Director
Eli Lilly & Co. (LLY) 19-Apr-21Grant 10$189.64$1,896.40< 1%
59.82K to 59.83K
< 1%
21-Apr-21 4:27 PM
View: 
Johnson Kimberly H
Director
Eli Lilly & Co. (LLY) 19-Apr-21Grant 51$189.64$9,671.64100%
51 to 0.1K
< 1%
17-Mar-21 4:41 PM
View: 
Alvarez Ralph
Director
Eli Lilly & Co. (LLY) 15-Mar-21Grant 58$189.16$10,971.30< 1%
49.4K to 49.46K
< 1%
17-Mar-21 4:38 PM
View: 
Tai Jackson P
Director
Eli Lilly & Co. (LLY) 15-Mar-21Grant 10$189.16$1,891.60< 1%
59.81K to 59.82K
< 1%
17-Mar-21 4:36 PM
View: 
Johnson Kimberly H
Director
Eli Lilly & Co. (LLY) 15-Mar-21Grant 51$189.16$9,647.16100%
0 to 51
< 1%
10-Mar-21 2:59 PM
View: 
Lilly Endowment Inc
10% Owner
Eli Lilly & Co. (LLY) 09-Mar-21Market Sale 59,959$209.79$12,579,000.00(< 1%)
110.36M to 110.3M
2%
09-Mar-21 12:26 PM
View: 
Lilly Endowment Inc
10% Owner
Eli Lilly & Co. (LLY) 08-Mar-21Market Sale 125,284$209.69$26,271,100.00(< 1%)
110.49M to 110.36M
1%
03-Mar-21 5:19 PM
View: 
Hakim Anat
SVP, GC & Secretary
Eli Lilly & Co. (LLY) 01-Mar-21Payment of Exercise 3,493$204.89$715,681.00(44%)
7.93K to 4.43K
03-Mar-21 5:19 PM
View: 
Hakim Anat
SVP, GC & Secretary
Eli Lilly & Co. (LLY) 01-Mar-21Option Exercise 7,928----100%
0 to 7.93K
18-Feb-21 4:26 PM
View: 
Alvarez Ralph
Director
Eli Lilly & Co. (LLY) 16-Feb-21Grant 53$207.76$11,011.30< 1%
49.15K to 49.2K
(< 1%)
18-Feb-21 4:29 PM
View: 
Tai Jackson P
Director
Eli Lilly & Co. (LLY) 16-Feb-21Grant 10$205.76$2,057.60< 1%
59.74K to 59.75K
< 1%
10-Feb-21 8:41 PM
View: 
Ricks David A
President & CEO
Director
Eli Lilly & Co. (LLY) 08-Feb-21Grant 130,343$205.77$26,820,700.0041%
316.83K to 447.18K
(2%)
10-Feb-21 8:39 PM
View: 
Pusey Leigh Ann
SVP, Corp. Affairs & Comm.
Eli Lilly & Co. (LLY) 08-Feb-21Grant 10,791$205.77$2,220,460.00139%
7.74K to 18.53K
(2%)
10-Feb-21 8:50 PM
View: 
Yuffa Ilya
SVP and Pres, Lilly Bio-Meds
Eli Lilly & Co. (LLY) 08-Feb-21Grant 3,536$205.77$727,603.0052%
6.81K to 10.35K
(2%)
10-Feb-21 8:51 PM
View: 
Zakrowski Donald A
Chief Accounting Officer
Eli Lilly & Co. (LLY) 08-Feb-21Grant 4,247$205.77$873,905.0066%
6.39K to 10.64K
(2%)
10-Feb-21 8:29 PM
View: 
Barnes Melissa S
Chief Eth/Cmpl Ofcr & SVP, ERM
Eli Lilly & Co. (LLY) 08-Feb-21Grant 9,594$205.77$1,974,160.0037%
25.95K to 35.54K
(2%)
10-Feb-21 8:46 PM
View: 
Smiley Joshua L
Eli Lilly & Co. (LLY) 08-Feb-21Grant 25,409$205.77$5,228,410.0047%
54.4K to 79.81K
(2%)
10-Feb-21 8:31 PM
View: 
Fry Stephen F
SVP, HR & Diversity
Eli Lilly & Co. (LLY) 08-Feb-21Grant 26,133$205.77$5,377,390.0024%
108.72K to 134.85K
(2%)
10-Feb-21 8:34 PM
View: 
Mason Michael B
Sr. VP & Pres., Lilly Diabetes
Eli Lilly & Co. (LLY) 08-Feb-21Grant 6,350$205.77$1,306,640.0032%
19.77K to 26.12K
(2%)
10-Feb-21 8:27 PM
View: 
Ashkenazi Anat
SVP & CFO
Eli Lilly & Co. (LLY) 08-Feb-21Grant 7,975$205.77$1,641,020.0044%
17.95K to 25.93K
(2%)
10-Feb-21 8:37 PM
View: 
O'Neill Myles
SVP & Pres., Mfg. Operations
Eli Lilly & Co. (LLY) 08-Feb-21Grant 21,052$205.77$4,331,870.0034%
61.87K to 82.92K
(2%)
10-Feb-21 8:53 PM
View: 
Zulueta Alfonso G
SVP & President, Lilly Int'l
Eli Lilly & Co. (LLY) 08-Feb-21Grant 29,037$205.77$5,974,940.0089%
32.58K to 61.61K
(2%)
10-Feb-21 8:43 PM
View: 
Shah Aarti S.
SVP & CIDO
Eli Lilly & Co. (LLY) 08-Feb-21Grant 11,033$205.77$2,270,260.0047%
23.56K to 34.59K
(2%)
10-Feb-21 8:36 PM
View: 
Norton Johna
Senior VP, Global Quality
Eli Lilly & Co. (LLY) 08-Feb-21Grant 6,040$205.77$1,242,850.0027%
22.7K to 28.74K
(2%)
10-Feb-21 8:44 PM
View: 
Skovronsky Daniel
SVP, CSO, and Pres. LRL
Eli Lilly & Co. (LLY) 08-Feb-21Grant 18,521$205.77$3,811,070.0019%
97.16K to 115.68K
(2%)
10-Feb-21 8:32 PM
View: 
Jonsson Patrik
SVP & President Lilly USA
Eli Lilly & Co. (LLY) 08-Feb-21Grant 5,595$205.77$1,151,280.0022%
25.51K to 31.1K
(2%)
10-Feb-21 8:48 PM
View: 
White Anne E.
SVP & Pres-Lilly Oncology
Eli Lilly & Co. (LLY) 08-Feb-21Grant 4,718$205.77$970,823.0016%
29.12K to 33.84K
(2%)
03-Feb-21 6:43 PM
View: 
O'Neill Myles
SVP & Pres., Mfg. Operations
Eli Lilly & Co. (LLY) 01-Feb-21Payment of Exercise 5,438$207.97$1,130,940.00(8%)
67.31K to 61.87K
03-Feb-21 6:33 PM
View: 
Fry Stephen F
SVP, HR & Diversity
Eli Lilly & Co. (LLY) 01-Feb-21Option Exercise 15,078----15%
100.39K to 115.47K
03-Feb-21 7:26 PM
View: 
Zulueta Alfonso G
SVP & President, Lilly Int'l
Eli Lilly & Co. (LLY) 01-Feb-21Payment of Exercise 7,490$207.97$1,557,700.00(19%)
40.07K to 32.58K
03-Feb-21 8:22 PM
View: 
Smiley Joshua L
SVP and CFO
Eli Lilly & Co. (LLY) 01-Feb-21Option Exercise 19,266----44%
43.59K to 62.85K
03-Feb-21 7:02 PM
View: 
Shah Aarti S.
SVP & CIDO
Eli Lilly & Co. (LLY) 01-Feb-21Payment of Exercise 2,780$207.97$578,157.00(11%)
26.34K to 23.56K
03-Feb-21 6:38 PM
View: 
Norton Johna
Senior VP, Global Quality
Eli Lilly & Co. (LLY) 01-Feb-21Payment of Exercise 1,529$207.97$317,986.00(6%)
24.23K to 22.7K
03-Feb-21 6:29 PM
View: 
Barnes Melissa S
Chief Eth/Cmpl Ofcr & SVP, ERM
Eli Lilly & Co. (LLY) 01-Feb-21Option Exercise 5,445----24%
22.91K to 28.35K
03-Feb-21 6:57 PM
View: 
Ricks David A
President & CEO
Director
Eli Lilly & Co. (LLY) 01-Feb-21Payment of Exercise 33,738$207.97$7,016,490.00(10%)
350.57K to 316.83K
03-Feb-21 6:43 PM
View: 
O'Neill Myles
SVP & Pres., Mfg. Operations
Eli Lilly & Co. (LLY) 01-Feb-21Option Exercise 12,146----22%
55.16K to 67.31K
03-Feb-21 7:26 PM
View: 
Zulueta Alfonso G
SVP & President, Lilly Int'l
Eli Lilly & Co. (LLY) 01-Feb-21Option Exercise 16,754----72%
23.31K to 40.07K
03-Feb-21 6:51 PM
View: 
Pusey Leigh Ann
SVP, Corp. Affairs & Comm.
Eli Lilly & Co. (LLY) 01-Feb-21Payment of Exercise 2,854$207.97$593,546.00(27%)
10.59K to 7.74K